UNIV GRIFFITH has a total of 338 patent applications. It increased the IP activity by 35.0%. Its first patent ever was published in 1983. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are UNIV ARKANSAS, ALBANY MEDICAL COLLEGE and UNIV TEXAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 92 | |
#2 | WIPO (World Intellectual Property Organization) | 77 | |
#3 | EPO (European Patent Office) | 29 | |
#4 | United States | 28 | |
#5 | China | 23 | |
#6 | Canada | 18 | |
#7 | Brazil | 10 | |
#8 | Republic of Korea | 10 | |
#9 | Mexico | 10 | |
#10 | Singapore | 10 | |
#11 | New Zealand | 7 | |
#12 | Netherlands | 6 | |
#13 | South Africa | 5 | |
#14 | Israel | 2 | |
#15 | Philippines | 2 | |
#16 | Germany | 1 | |
#17 | Hong Kong | 1 | |
#18 | Hungary | 1 | |
#19 | India | 1 | |
#20 | Japan | 1 | |
#21 | Luxembourg | 1 | |
#22 | Malaysia | 1 | |
#23 | Russian Federation | 1 | |
#24 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Environmental technology | |
#6 | Semiconductors | |
#7 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Sugars | |
#7 | Climate change adaptation technologies | |
#8 | Heterocyclic compounds | |
#9 | Semiconductor devices | |
#10 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Good Michael | 32 |
#2 | Pandey Manisha | 25 |
#3 | Davis Christopher Bonner | 22 |
#4 | Thomson Robin Joy | 21 |
#5 | Von Itzstein Mark | 17 |
#6 | Von Itzstein Laurence Mark | 16 |
#7 | Mahalingam Surendran | 16 |
#8 | Jennings Michael Paul | 14 |
#9 | Dimitrijev Sima | 12 |
#10 | Griffiths Lynette Robyn | 12 |
Publication | Filing date | Title |
---|---|---|
WO2021068033A1 | Anode material | |
WO2021051153A1 | Protein particles comprising a diphtheria toxin cross reacting material (crm) amino acid sequence and uses thereof | |
US2021069180A1 | Methods for treating chronic fatigue syndrome and myalgic encephalomyelitis | |
WO2021016670A1 | Antiviral agents and uses thereof | |
WO2020243781A1 | Biospine: a digtial twin neurorehabilitation system | |
WO2020124159A1 | Compositions, methods and uses for eliciting an immune response | |
WO2021072474A1 | Method of calculating in vivo force on an anterior cruciate ligament | |
AU2019362276A1 | Virus vaccine | |
LU101432B1 | Electrohydrodynamic atomizer | |
WO2020061649A1 | Agents and methods for modulating pathogen activity | |
NL2023306B1 | Optoelectronic coupling platforms and sensors | |
NL2023270B1 | Securement device and securement kit | |
CA3100212A1 | Streptococcal toxic shock syndrome | |
WO2019113646A1 | Sulfation method | |
WO2019084622A1 | Cell culture system | |
NL2021903B1 | Ventricular assistance system and method | |
WO2019071297A1 | Apparatus for and methods of removing fluid from a cell culture | |
SG11202001557PA | Immunogenic peptide against group a streptococcus | |
EP3664746A1 | Multiphasic tissue scaffold constructs | |
EP3646015A1 | A sensor |